Takai D - Search Results

1

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.

Nasu I, Kondo M, Uozumi R, Takada S, Nawata S, Iihara H, Okumura Y, Takemoto M, Mino K, Sasaki T, Hirose C, Aomori T, Shimano R, Maeno K, Oizumi S, Kusumoto S, Ohno Y, Ikemura S, Takai D, Hara A, Kawazoe H, Nakamura T. Nasu I, et al. Among authors: takai d. J Cancer. 2023 Mar 11;14(5):676-688. doi: 10.7150/jca.80517. eCollection 2023. J Cancer. 2023. PMID: 37056385 Free PMC article.

2

Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.

Ando T, Kage H, Matsumoto Y, Zokumasu K, Yotsumoto T, Maemura K, Amano Y, Watanabe K, Nakajima J, Nagase T, Takai D. Ando T, et al. Among authors: takai d. Cancer Sci. 2020 Jan;111(1):200-208. doi: 10.1111/cas.14257. Epub 2019 Dec 18. Cancer Sci. 2020. PMID: 31778288 Free PMC article.

3

Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Kawakami M, Ishikawa R, Amano Y, Sunohara M, Watanabe K, Ohishi N, Yatomi Y, Nakajima J, Fukayama M, Nagase T, Takai D. Kawakami M, et al. Among authors: takai d. Cancer Sci. 2013 Nov;104(11):1447-54. doi: 10.1111/cas.12250. Epub 2013 Sep 5. Cancer Sci. 2013. PMID: 23931849 Free PMC article.

4

CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer.

Kitano K, Watanabe K, Emoto N, Kage H, Hamano E, Nagase T, Sano A, Murakawa T, Nakajima J, Goto A, Fukayama M, Yatomi Y, Ohishi N, Takai D. Kitano K, et al. Among authors: takai d. Cancer Sci. 2011 Dec;102(12):2126-31. doi: 10.1111/j.1349-7006.2011.02101.x. Epub 2011 Oct 12. Cancer Sci. 2011. PMID: 21917081 Free article.

5

Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.

Ichinose J, Watanabe K, Sano A, Nagase T, Nakajima J, Fukayama M, Yatomi Y, Ohishi N, Takai D. Ichinose J, et al. Among authors: takai d. Cancer Sci. 2014 Sep;105(9):1135-41. doi: 10.1111/cas.12472. Epub 2014 Sep 3. Cancer Sci. 2014. PMID: 24975429 Free PMC article.

6

Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.

Watanabe K, Emoto N, Hamano E, Sunohara M, Kawakami M, Kage H, Kitano K, Nakajima J, Goto A, Fukayama M, Nagase T, Yatomi Y, Ohishi N, Takai D. Watanabe K, et al. Among authors: takai d. Int J Cancer. 2012 Jun 1;130(11):2580-90. doi: 10.1002/ijc.26254. Epub 2011 Sep 17. Int J Cancer. 2012. PMID: 21702040

7

Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.

Watanabe K, Amano Y, Ishikawa R, Sunohara M, Kage H, Ichinose J, Sano A, Nakajima J, Fukayama M, Yatomi Y, Nagase T, Ohishi N, Takai D. Watanabe K, et al. Among authors: takai d. Cancer Med. 2015 Oct;4(10):1573-82. doi: 10.1002/cam4.505. Epub 2015 Aug 8. Cancer Med. 2015. PMID: 26256448 Free PMC article.

8

Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.

Maemura K, Watanabe K, Ando T, Hiyama N, Sakatani T, Amano Y, Kage H, Nakajima J, Yatomi Y, Nagase T, Takai D. Maemura K, et al. Among authors: takai d. Cancer Sci. 2018 Oct;109(10):3326-3335. doi: 10.1111/cas.13742. Epub 2018 Sep 6. Cancer Sci. 2018. PMID: 30022565 Free PMC article.

9

Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.

Takahara N, Nakai Y, Isayama H, Sasaki T, Satoh Y, Takai D, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tada M, Yatomi Y, Koike K. Takahara N, et al. Among authors: takai d. Cancer Chemother Pharmacol. 2013 Jan;71(1):85-92. doi: 10.1007/s00280-012-1981-0. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2013. PMID: 23053265 Clinical Trial.

10

[Aberrant methylation of circulating DNA for prediction of chemo-sensitivity of non-small cell lung cancer].

Takai D. Takai D. Gan To Kagaku Ryoho. 2010 Feb;37(2):189-93. Gan To Kagaku Ryoho. 2010. PMID: 20154471 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters